| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.009 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.44 | 0.009 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |